PWE Stock Overview
An investment holding company, operates as a medical device company in China, India, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
PW Medtech Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.11 |
| 52 Week High | HK$0.14 |
| 52 Week Low | HK$0.07 |
| Beta | 0.75 |
| 1 Month Change | -1.82% |
| 3 Month Change | -3.57% |
| 1 Year Change | 48.97% |
| 3 Year Change | 2.86% |
| 5 Year Change | -30.77% |
| Change since IPO | -66.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| PWE | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -2.6% |
| 1Y | 49.0% | -8.5% | 6.9% |
Return vs Industry: PWE exceeded the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: PWE exceeded the German Market which returned 6.9% over the past year.
Price Volatility
| PWE volatility | |
|---|---|
| PWE Average Weekly Movement | 14.7% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PWE's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PWE's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,302 | Yue'e Zhang | www.pwmedtech.com |
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, North America, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, and hemoperfutors; and animal-derived regenerative medical biomaterials and human tissue repair alternative products.
PW Medtech Group Limited Fundamentals Summary
| PWE fundamental statistics | |
|---|---|
| Market cap | €181.78m |
| Earnings (TTM) | €20.02m |
| Revenue (TTM) | €91.23m |
9.1x
P/E Ratio2.0x
P/S RatioIs PWE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PWE income statement (TTM) | |
|---|---|
| Revenue | CN¥694.49m |
| Cost of Revenue | CN¥302.77m |
| Gross Profit | CN¥391.72m |
| Other Expenses | CN¥239.29m |
| Earnings | CN¥152.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 56.40% |
| Net Profit Margin | 21.95% |
| Debt/Equity Ratio | 0.06% |
How did PWE perform over the long term?
See historical performance and comparisonDividends
9.2%
Current Dividend Yield88%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:25 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PW Medtech Group Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jessica Li | BofA Global Research |
| Kevin Leung | Haitong International Research Limited (Inactive) |
| Bin Li | Morgan Stanley |